tradingkey.logo
tradingkey.logo
Buscar

Prophase Labs Inc

PRPH
Añadir a la lista de seguimiento
0.363USD
0.0000.00%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
1.09MCap. mercado
PérdidaP/E TTM

Más Datos de Prophase Labs Inc Compañía

ProPhase Labs, Inc. is a biotech, genomics, and consumer products company. The Company is engaged in providing whole genome sequencing solutions, diagnostic development, such as its potentially life-saving test for the early detection of esophageal cancer and a direct-to-consumer marketing platform for OTC dietary supplements. It develops, manufactures, and commercializes health and wellness solutions. Its Diagnostic services segment provides diagnostic information services to a range of customers in the United States, including health plans, third-party payers and government organizations. Its Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and provides personal genomics products and services. The Company also develops and markets dietary supplements under the TK Supplement brand, which includes Legendz XL and Triple Edge XL.

Información de Prophase Labs Inc

Símbolo de cotizaciónPRPH
Nombre de la empresaProphase Labs Inc
Fecha de salida a bolsaJan 16, 1984
Director ejecutivoKarkus (Ted William)
Número de empleados96
Tipo de seguridadOrdinary Share
Fin del año fiscalJan 16
Dirección711 Stewart Ave, Suite 200
CiudadNEW YORK
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal11530
Teléfono12153450919
Sitio Webhttps://www.prophaselabs.com/
Símbolo de cotizaciónPRPH
Fecha de salida a bolsaJan 16, 1984
Director ejecutivoKarkus (Ted William)

Ejecutivos de Prophase Labs Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ted William Karkus
Mr. Ted William Karkus
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
321.53K
--
Dr. Louis Gleckel, M.D.
Dr. Louis Gleckel, M.D.
Independent Director
Independent Director
10.38K
--
Mr. Warren Hirsch, CPA
Mr. Warren Hirsch, CPA
Independent Director
Independent Director
--
--
Ms. Carolina Abenante, Esq.
Ms. Carolina Abenante, Esq.
Independent Director
Independent Director
--
--
Mr. Steven M. Plumb, CPA
Mr. Steven M. Plumb, CPA
Fractional Chief Financial Officer
Fractional Chief Financial Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ted William Karkus
Mr. Ted William Karkus
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
321.53K
--
Dr. Louis Gleckel, M.D.
Dr. Louis Gleckel, M.D.
Independent Director
Independent Director
10.38K
--
Mr. Warren Hirsch, CPA
Mr. Warren Hirsch, CPA
Independent Director
Independent Director
--
--
Ms. Carolina Abenante, Esq.
Ms. Carolina Abenante, Esq.
Independent Director
Independent Director
--
--
Mr. Steven M. Plumb, CPA
Mr. Steven M. Plumb, CPA
Fractional Chief Financial Officer
Fractional Chief Financial Officer
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Prophase Labs Inc?

Los cinco principales accionistas de Prophase Labs Inc son: Mr. Ted William Karkus

¿Cuántas instituciones poseen acciones de Prophase Labs Inc (PRPH)?

A fecha de 2026Q1, 81 instituciones poseen acciones de Prophase Labs Inc, con un valor de mercado combinado de aproximadamente 129.97K, lo que representa el 1.98% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -543519.00.